Summary
athenahealth's More Disruption Please (MDP) is an innovative program that connects entrepreneurs, healthcare IT companies, investors and thought leaders pioneering changes to the healthcare industry. Goodwin Procter is a sponsor of this annual event.
Related Content
- Big Molecule WatchMay 21, 2025
Biogen Files Suit Against Neurimmune Over Rights to Bispecific Antibody
- Big Molecule WatchMay 21, 2025
HyClone Seeks to Quash Amgen’s Subpoena Issued in Amgen/Accord Denosumab BPCIA Litigation
- Big Molecule WatchMay 19, 2025
Regeneron Awarded $407 Million in Amgen Antitrust Suit
- Big Molecule WatchMay 16, 2025
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with STELARA (ustekinumab)
- Big Molecule WatchMay 16, 2025
Join Us! The Future of Biotech Regulation Webinar
- Big Molecule WatchMay 15, 2025
Third Circuit Affirms Rejection of AstraZeneca’s Challenges to IRA Drug Price Negotiation Program
- Big Molecule WatchMay 15, 2025
President Trump Issues Two Executive Orders Concerning the Affordability and Accessibility of Drugs
- Life Sciences PerspectivesMay 14, 2025
Antitrust Life Sciences Quarterly Update 2025 Q1
- Awards and RankingsMay 22, 2025
Goodwin Named to Los Angeles Business Journal’s 2025 List of Largest Law Firms in LA
- Press ReleaseMay 22, 2025
Vigil Neuroscience To Be Acquired by Sanofi For 470 Million and Contingent Value Rights
- Press ReleaseMay 19, 2025
Goodwin Represents Inozyme Pharma in $270 Million Acquisition by BioMarin to Strengthen Enzyme Therapy Business
- Press ReleaseMay 12, 2025
Goodwin Scales Life Sciences Practice in Boston with the Arrival of Partner Felipe Heiderich
- In the PressMay 6, 2025
Rare Disease Industry Awaits FDA Chief’s New Drug Pathway Plan (Bloomberg Law)
- In the PressMay 1, 2025
AI in Healthcare: Private Equity’s Next Frontier? (Real Deals)
- Press ReleaseMay 1, 2025
Kronos Bio To Be Taken Private by Concentra Biosciences
- Press ReleaseMay 1, 2025
Goodwin Welcomes Leading Life Sciences and Intellectual Property Partner William T. Christiansen II Ph.D.